Siddharth Kaul
Director/Board Member presso IMMUNOCORE HOLDINGS PLC
Patrimonio netto: - $ in data 31/03/2024
Profilo
Siddharth Kaul is currently serving as the Director at Helsinn Healthcare SA since 2022.
He is also an Independent Non-Executive Director at Immunocore Holdings Plc since 2022.
Additionally, Mr. Kaul holds the position of Non-Executive Director at Immunocore Ltd.
Mr. Kaul previously worked as the Chief Financial Officer-Pharma Europe at Novartis AG in 2021.
He holds an MBA from Indiana University and an undergraduate degree from West Virginia University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
IMMUNOCORE HOLDINGS PLC
-.--% | 02/01/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Siddharth Kaul
| Società | Posizione | Inizio |
|---|---|---|
| IMMUNOCORE HOLDINGS PLC | Director/Board Member | 08/06/2022 |
Helsinn Healthcare SA
 Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland. | Director/Board Member | 15/01/2022 |
Immunocore Ltd.
 Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The private company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal. | Director/Board Member | - |
Precedenti posizioni note di Siddharth Kaul
| Società | Posizione | Fine |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | 01/04/2021 |
Formazione di Siddharth Kaul
| Indiana University | Masters Business Admin |
| West Virginia University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| NOVARTIS AG | Health Technology |
| IMMUNOCORE HOLDINGS PLC | Health Technology |
| Aziende private | 2 |
|---|---|
Helsinn Healthcare SA
Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland. | Health Technology |
Immunocore Ltd.
Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The private company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal. | Health Technology |
- Borsa valori
- Insiders
- Siddharth Kaul
